ProBio vs Swiss BioQuant AG

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/probio/swissbioquant

Category	ProBio	Swiss BioQuant AG
Listed site	both	cro
Summary	ProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.	Bioanalytical CRO offering LC-MS/MS and ligand-binding assay development, validation, and sample analysis for small and large molecules. Work runs in a 21 CFR Part 11 compliant environment, with qPCR support for gene therapy bioanalysis.
Services	Analytical Method Development & Validation ICH Stability Studies In Vitro Pharmacology Protein Engineering Bioanalysis Flow Cytometry Services Immunogenicity Assays (ADA / NAb)	Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Biomarker Assays Immunogenicity Assays (ADA / NAb) In Vivo PK / PD Studies
Modalities	Biologics (Monoclonal Antibodies) Biologics (Other) mRNA Cell Therapy Gene Therapy Vaccine AAV / Viral Vector Platform	Small Molecule Biologics (Monoclonal Antibodies) Peptide Biologics (Other) Gene Therapy Cell Therapy
Indications	Infectious Disease	Data not yet provided.
Locations	United States, United States Netherlands, Netherlands South Korea, South Korea Hong Kong, Hong Kong, China Shanghai, Shanghai, China Nanjing, Nanjing, China	Data not yet provided.
Certifications	FDA · Identifier: US Food and Drug Administration EMA · Identifier: European Medicines Agency NMPA · Identifier: National Medical Products Administration	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.